Hongbing Liu, Yueqin Ai, Zhaofeng Wang, Dongmei Yuan, Ping Zhan, Yanwen Yao. "Camrelizumab combined with 2 cycles of chemotherapy as first-line treatment for advanced non-small cell lung cancer (NSCLC): A two-arm, single-center, phase 2 study.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.8548